n-(2-hydroxypropyl)methacrylamide has been researched along with Carcinoma 256, Walker in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allmeroth, M; Buchholz, HG; Gündel, D; Koynov, K; Moderegger, D; Mohr, K; Rösch, F; Thews, O; Zentel, R | 1 |
1 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Carcinoma 256, Walker
Article | Year |
---|---|
HPMA-LMA copolymer drug carriers in oncology: an in vivo PET study to assess the tumor line-specific polymer uptake and body distribution.
Topics: Animals; Carcinoma 256, Walker; Male; Methacrylates; Nanoparticles; Neoplasm Transplantation; Particle Size; Polymethacrylic Acids; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Tissue Distribution; Whole Body Imaging | 2013 |